Philip Morris International to Present at 2023 Morgan Stanley Global Consumer & Retail Conference
28 Novembre 2023 - 6:07PM
Business Wire
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM)’s Chief
Financial Officer, Emmanuel Babeau, will hold a Fireside Chat
Q&A session at the 2023 Morgan Stanley Global Consumer &
Retail Conference on Tuesday, December 5, 2023, at 09:30 a.m.
ET.
The live webcast will be available at
www.pmi.com/2023morganstanley. The webcast replay will be available
at the same link until Friday, January 5, 2024.
The webcast may also be accessed on mobile devices by
downloading PMI’s Investor Relations App at www.pmi.com/irapp.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products.
Since 2008, PMI has invested more than USD 10.5 billion to develop,
scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the
goal of completely ending the sale of cigarettes. This includes the
building of world-class scientific assessment capabilities, notably
in the areas of pre-clinical systems toxicology, clinical and
behavioral research, as well as post-market studies. In November
2022, PMI acquired Swedish Match – a leader in oral nicotine
delivery – creating a global smoke-free champion led by the
companies’ IQOS and ZYN brands. The U.S. Food and Drug
Administration has authorized versions of PMI’s IQOS Platform 1
devices and consumables and Swedish Match’s General snus as
Modified Risk Tobacco Products. As of September 30, 2023, PMI's
smoke-free products were available for sale in 82 markets, and PMI
estimates that approximately 19.7 million adults around the world
had already switched to IQOS and stopped smoking. Smoke-free
products accounted for approximately 36.2% of PMI’s total
third-quarter 2023 net revenues. With a strong foundation and
significant expertise in life sciences, PMI announced in February
2021 its ambition to expand into wellness and healthcare areas and,
through its Vectura Fertin Pharma business, aims to enhance life
through the delivery of seamless health experiences. For more
information, please visit www.pmi.com and www.pmiscience.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128122951/en/
Philip Morris International Investor Relations: Stamford,
CT: +1 (203) 905 2413 Lausanne: +41 (0) 58 242 4666 Email:
InvestorRelations@pmi.com Media: David Fraser Lausanne: +41 (0)58
242 4500 Email: David.Fraser@pmi.com
Grafico Azioni Philip Morris (NYSE:PM)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Philip Morris (NYSE:PM)
Storico
Da Mag 2023 a Mag 2024